D
Dipak K. Das
Researcher at University of Connecticut
Publications - 329
Citations - 18415
Dipak K. Das is an academic researcher from University of Connecticut. The author has contributed to research in topics: Ischemia & Resveratrol. The author has an hindex of 75, co-authored 327 publications receiving 17708 citations. Previous affiliations of Dipak K. Das include Jawaharlal Nehru University & Baystate Medical Center.
Papers
More filters
Journal ArticleDOI
Protection from nonfreezing cold injury by quinacrine, a phospholipase inhibitor.
TL;DR: Quinacrine reduced the release of these intracellular enzymes and decreased lipid peroxidation, suggesting its efficacy as a therapeutic agent against hypothermic injury.
Journal ArticleDOI
Health benefits of wine and alcohol from neuroprotection to heart health.
TL;DR: The authors found that light/moderate alcohol/wine consumers have lower risks of age-dependent cognitive decline and/or dementia, including Alzheimer's disease (AD) and Parkinson's (PD) diseases.
Journal Article
Resveratrol and health
Ole Vang,Dipak K. Das +1 more
TL;DR: This volume examines the phytoalexin resveratrol and the ongoing studies about its effects on lifespan and health and is sold as a nutritional supplement derived primarily from Japanese knotweed.
Journal ArticleDOI
Tocotrienols confer resistance to ischemia in hypercholesterolemic hearts: insight with genomics
Somak Das,Subhendu Mukherjee,Istvan Lekli,Istvan Lekli,Narasimman Gurusamy,Jayeeta Bardhan,Utpal Raychoudhury,Runu Chakravarty,Sandip Banerji,Anne A Knowlton,Dipak K. Das +10 more
TL;DR: The results of the present study demonstrate that the two isomers of tocotrienols, α and γ, render the hypercholesterolemic hearts resistant to ischemic reperfusion injury by lowering several hypercholesterololemic proteins including MMP2, MMP9, ET-1, and SPOT 14 and upregulating TGF-β.
Journal ArticleDOI
Improvement of myocardial function by trifluoperazine, a calmodulin antagonist, after acute coronary artery occlusion and coronary revascularization.
Hajime Otani,Richard M. Engelman,John A. Rousou,Robert H. Breyer,Ronald Clement,Renuka Prasad,Janelle Klar,Dipak K. Das +7 more
TL;DR: It is suggested that trifluoperazine improved regional myocardial function after acute occlusion of the left anterior descending artery and reperfusion and that global cardiac performance was thereby improved.